# Integrated fetal testicular transcriptomic and epigenomic profiles during maternal nutrient restriction with dietary melatonin intervention

**Authors:** Hala El Daous, Brittni P Littlejohn, Zully E Contreras-Correa, Shiveeli Rajput, Darcie R Sidelinger, E Heath King, Mark A Arick, Caleb O Lemley

PMC · DOI: 10.1093/jas/skaf455 · Journal of Animal Science · 2026-01-09

## TL;DR

This study shows how melatonin can help counteract the negative effects of poor maternal nutrition on fetal testis development by altering gene activity and DNA methylation.

## Contribution

The study integrates transcriptomic and epigenomic data to reveal how melatonin supplementation affects fetal testis development under maternal nutrient restriction.

## Key findings

- Melatonin supplementation altered gene expression and DNA methylation in fetal testes under nutrient restriction.
- Specific genes like DAAM1 and KYAT1 showed significant expression changes with melatonin.
- Nutrient restriction alone caused 370 DMRs without corresponding gene expression changes.

## Abstract

Fetal development is a critical period that establishes reproductive efficiency and herd performance depending on in-utero epigenetic modifications. Dietary restrictions may affect fetal testis development and the offspring fertility. Several studies have connected genetic instability to circadian cycle disruptions, including epigenetic modifications to melatonin, a key regulator. On day 160 of gestation, 17 male-bearing Brangus heifers were assigned to one of four groups in a 2 × 2 factorial treatment arrangement: adequately fed (ADQ; 100% NRC recommendation, n = 3), nutrient restricted (RES; 60% NRC recommendation, n = 5), or ADQ or RES supplemented with 20 mg/d melatonin (ADQ-MEL, n = 5; RES-MEL, n = 4). On day 240 of gestation, heifers underwent Cesarean sections to collect fetuses and testicular tissues. The fetal testicular tissue was processed and analyzed using the Methyl-MiniSeq Service: Genome-wide bisulfite sequencing (Methyl MiniSeq-GWBS). Sequence reads from Methyl Mini-Seq libraries were identified using standard Illumina platform calling software for methylome profile. RNA-Seq libraries were then sequenced on the Illumina platform for transcriptome profile. The common genes between differentially methylated regions (DMRs) and differentially expressed genes (DEGs) across different treatment groups were identified by an overlap analysis using bedtools v2.31.1. There were 413 DMRs in RES-CON and ADQ-CON testicular tissues, without differential gene expression. Compared with the ADQ-CON group, the ADQ-MEL group showed 411 DMRs and a higher KYAT1 gene expression (P-adj <0.05) without methylation changes. Comparing RES-MEL with RES-CON showed that 9 genes (DAAM1, COL28A1, RPL10, TRPM3, SLIT, ARHGEF40, SYT1, TMEM35B, CSPG4B) were expressed more in the former (P-adj <0.05). The only hypomethylated gene was DAAM1 located on chromosome 10. However, 13 genes (PTPRU, snRNP-E, TMEM59L, MUC5B, ANAPC15, FAM221A, SHCBPiL, PAQR5, PPP4R3C, DTNB, LncRNA, SHANK2, RIC3) showed increased expression in RES-CON vs. RES-MEL without differential methylation alterations, yet there were 370 DMRs. Five genes showed increased expression in RES-MEL compared with ADQ-MEL (P-adj <0.05), including histone H2B on chromosome 23. Two genes (PTPRU, TDRD10) showed increased expression in ADQ-MEL compared with RES-MEL (P-adj <0.05) without affecting methylation and 344 DMRs. In conclusion, dietary melatonin supplementation to nutrient restricted dams may influence fetal development as epigenomic and transcriptomic regulators are altered.

Epigenetics offers a new way to study embryonic development, as it is affected by environmental influences and the causes of illness. Understanding how dietary limitation and/or melatonin supplementation alter epigenetic modifications would help us optimize pregnant cow management and male offspring development through nutritional manipulation, offering a physiological alternative to pharmacotherapies.

## Linked entities

- **Genes:** KYAT1 (kynurenine aminotransferase 1) [NCBI Gene 883], DAAM1 (dishevelled associated activator of morphogenesis 1) [NCBI Gene 23002], COL28A1 (collagen type XXVIII alpha 1 chain) [NCBI Gene 340267], RPL10 (ribosomal protein L10) [NCBI Gene 6134], TRPM3 (transient receptor potential cation channel subfamily M member 3) [NCBI Gene 80036], sli (slit) [NCBI Gene 36746], ARHGEF40 (Rho guanine nucleotide exchange factor 40) [NCBI Gene 55701], SYT1 (synaptotagmin 1) [NCBI Gene 6857], TMEM35B (transmembrane protein 35B) [NCBI Gene 100506144], Cspg4b (chondroitin sulfate proteoglycan 4B) [NCBI Gene 294747], PTPRU (protein tyrosine phosphatase receptor type U) [NCBI Gene 10076], SNRPE (small nuclear ribonucleoprotein polypeptide E) [NCBI Gene 6635], TMEM59L (transmembrane protein 59 like) [NCBI Gene 25789], MUC5B (mucin 5B, oligomeric mucus/gel-forming) [NCBI Gene 727897], ANAPC15 (anaphase promoting complex subunit 15) [NCBI Gene 25906], FAM221A (family with sequence similarity 221 member A) [NCBI Gene 340277], PAQR5 (progestin and adipoQ receptor family member 5) [NCBI Gene 54852], PPP4R3C (protein phosphatase 4 regulatory subunit 3C) [NCBI Gene 139420], DTNB (dystrobrevin beta) [NCBI Gene 1838], SHANK2 (SH3 and multiple ankyrin repeat domains 2) [NCBI Gene 22941], RIC3 (RIC3 acetylcholine receptor chaperone) [NCBI Gene 79608], H2BC21 (H2B clustered histone 21) [NCBI Gene 8349], TDRD10 (tudor domain containing 10) [NCBI Gene 126668]
- **Chemicals:** melatonin (PubChem CID 896)

## Full-text entities

- **Genes:** COL28A1 (collagen type XXVIII alpha 1 chain) [NCBI Gene 340267] {aka COL28}, PAQR5 (progestin and adipoQ receptor family member 5) [NCBI Gene 54852] {aka MPRG}, ARHGEF40 (Rho guanine nucleotide exchange factor 40) [NCBI Gene 55701] {aka SOLO}, SYT1 (synaptotagmin 1) [NCBI Gene 6857] {aka BAGOS, P65, SVP65, SYT}, FAM221A (family with sequence similarity 221 member A) [NCBI Gene 340277] {aka C7orf46}, KYAT1 (kynurenine aminotransferase 1) [NCBI Gene 883] {aka CCBL1, GTK, KAT1, KATI}, PTPRU (protein tyrosine phosphatase receptor type U) [NCBI Gene 10076] {aka FMI, PCP-2, PTP, PTP-J, PTP-PI, PTP-RO}, DTNB (dystrobrevin beta) [NCBI Gene 1838], DAAM1 (dishevelled associated activator of morphogenesis 1) [NCBI Gene 23002], TRPM3 (transient receptor potential cation channel subfamily M member 3) [NCBI Gene 80036] {aka CTRCT50, GON-2, LTRPC3, MLSN2, NEDFSS}, ANAPC15 (anaphase promoting complex subunit 15) [NCBI Gene 25906] {aka APC15, C11orf51, HSPC020}, TMEM35B (transmembrane protein 35B) [NCBI Gene 100506144] {aka ZMYM6NB}, RPL10 (ribosomal protein L10) [NCBI Gene 6134] {aka AUTSX5, DXS648, DXS648E, L10, MRXS35, NOV}, MUC5B (mucin 5B, oligomeric mucus/gel-forming) [NCBI Gene 727897] {aka MG1, MUC-5B, MUC5, MUC9}, RIC3 (RIC3 acetylcholine receptor chaperone) [NCBI Gene 79608] {aka AYST720, PRO1385, RIC-3}, SNRPE (small nuclear ribonucleoprotein polypeptide E) [NCBI Gene 6635] {aka HYPT11, SME, Sm-E, snRNP-E}, TDRD10 (tudor domain containing 10) [NCBI Gene 126668], SHANK2 (SH3 and multiple ankyrin repeat domains 2) [NCBI Gene 22941] {aka AUTS17, CORTBP1, CTTNBP1, ProSAP1, SHANK, SPANK-3}, TMEM59L (transmembrane protein 59 like) [NCBI Gene 25789] {aka BSMAP, C19orf4}
- **Chemicals:** melatonin (MESH:D008550)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12863962/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12863962/full.md

## References

91 references — full list in the complete paper: https://tomesphere.com/paper/PMC12863962/full.md

---
Source: https://tomesphere.com/paper/PMC12863962